This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Io Therapeutics, Inc.
Drug Names(s): IRX05183
Description: IRX5183 is a third generation retinoid acting as a retinoic acid receptor-alpha (RAR-alpha) agonist. Studies have shown that IRX5183 promotes differentiation of immunosuppressive Tregs and inhibition of pro-inflammatory Th17 cells.
Additional information available to subscribers only: